Lv21
160 积分 2026-03-24 加入
P-090 Infections and Immune Reconstitution in the Phase 3 CARTITUDE-4 Trial of Ciltacabtagene Autoleucel vs Standard Care in Patients with Lenalidomide-Refractory Multiple Myeloma (MM) and 1–3 Prior Lines
13分钟前
求助中
Clarification of the definition of complete response in multiple myeloma
26天前
已关闭
CAR T‐Cell Therapy for Multiple Myeloma: A Clinical Practice‐Oriented Review
5个月前
已完结
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment
5个月前
已完结
CAR T-cells in multiple myeloma: the race to the start line
6个月前
已完结
Current progress of CAR-T-cell therapy for patients with multiple myeloma
6个月前
已完结
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
7个月前
已完结
Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion
7个月前
已完结
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies
7个月前
已完结
E. coli Expression and Purification of Fab Antibody Fragments
7个月前
已完结